[HTML][HTML] Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen, Y Su… - Clinical …, 2020 - Springer
Abstract Background While Alzheimer's disease (AD) remains one of the most challenging
diseases to tackle, genome-wide genetic/epigenetic studies reveal many disease …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen, Y Su… - Clinical …, 2020 - europepmc.org
Background While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen, Y Su… - Clinical …, 2020 - go.gale.com
Background While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen… - Clinical …, 2020 - asu.elsevierpure.com
Background: While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen… - Clinical …, 2020 - search.proquest.com
Background While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

[HTML][HTML] Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead… - Clinical …, 2020 - clinicalepigeneticsjournal …
While Alzheimer's disease (AD) remains one of the most challenging diseases to tackle,
genome-wide genetic/epigenetic studies reveal many disease-associated risk loci, which …

[HTML][HTML] Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen, Y Su… - Clinical …, 2020 - ncbi.nlm.nih.gov
Background While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen… - Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Background While Alzheimer's disease (AD) remains one of the most challenging diseases
to tackle, genome-wide genetic/epigenetic studies reveal many disease-associated risk loci …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen, Y Su… - Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
While Alzheimer's disease (AD) remains one of the most challenging diseases to tackle …

Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease …

Q Wang, Y Chen, B Readhead, K Chen… - Clinical …, 2020 - search.ebscohost.com
Abstract Background: While Alzheimer's disease (AD) remains one of the most challenging
diseases to tackle, genome-wide genetic/epigenetic studies reveal many disease …